<DOC>
	<DOCNO>NCT00351039</DOCNO>
	<brief_summary>This Phase I/II trial elderly patient ( &gt; 70 year age ) . Patients age group previously un-treated Advanced Stage Non-Squamous Non-Small Cell Lung Cancer ( NSCLC ) Stage IIIB ( malignant pleural effusion ) stage IV disease enrol . Therapy consist three drug ( Premetrexed [ Alimta™ ] , Bevacizumab Erlotinib [ Tarceva™ ] ) give every 28 day .</brief_summary>
	<brief_title>Phase I/II Trial Bevacizumab , Pemetrexed Erlotinib Elderly Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>This Phase I/II trial elderly patient ( &gt; 70 year age ) previously un-treated Advanced Stage Non-Squamous NSCLC Stage IIIB ( malignant pleural effusion ) stage IV disease enrol . Treatment Regimen : Premetrexed ( Alimta™ ) 500 milligram ( mg ) /Meter square ( m20 Intravenous ( I.V . ) Day 1 Day 15 ; Bevacizumab 10mg/Kilogram ( Kg ) I. V. Day 1 Day 15 ; Erlotinib ( Tarceva™ ) 150mg Per Orally ( PO ) Once Daily ( QD ) 7 day start day 2 day 15 ; Repeat cycle every 28 day . All three drug continue two cycle maximal response . After patient maintain Bevacizumab Erlotinib progression . If patient stable disease first two cycle patient give another two cycle three drug maintenance treatment Bevacizumab Erlotinib initiate .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Patient must histologically prove diagnosis NonSquamous NSCLC . NSCLC histology include trial adenocarcinoma , large cell carcinoma adenosquamous carcinoma . Patients bronchioloalveolar carcinoma ( BAC ) also include trial . Patients must 70 year age old . Patient must either stage IIIB disease malignant pleural effusion stage IV disease . All patient must measurable disease . Evaluable disease separately outline elucidate . Patients must Eastern Cooperative Oncology Group ( ECOG ) performance status either 0 1 . Patient must adequate renal function serum creatinine level le 1.5mg/dl patient calculate creatinine clearance 45ml/min . Patient must adequate hepatic function serum bilirubin level less 3mg/dl , alkaline phosphatase , Alanine Amino Transferase ( ALT ) Aspartate Amino Transferase ( AST ) less three time upper limit normal Patient must also evidence adequate bone marrow function absolute neutrophil count 1 , 500 cell per deciliter platelet count 100,000 per deciliter . Patients must 28 day since prior open biopsy ; 7 day since prior fineneedle aspiration ; 7 day since prior core biopsy ; 28 day since prior surgery . Patients must able take dexamethasone , folic acid vitamin B12 supplementation . All patient must sign informed consent detail investigational nature study accordance institutional federal guideline . Lung carcinoma squamous cell histology histology close proximity major vessel , without cavitation . Patients hypercalcemia ( correct calcium 11 mg/dl ) exclude . Patients history hemoptysis , hematemesis , coagulopathy thrombosis exclude . Patients require anticoagulation reason exclude . Patients recently acute infection . History palliative radiation therapy within 2 week . Blood pressure &gt; 150/100 Millimeter Mercury ( mmHg ) . Currently ongoing unstable angina . New York Heart Association ( NYHA ) Grade II great congestive heart failure . History myocardial infarction within 6 month . History stroke within 6 month . Clinically significant peripheral vascular disease . Presence central nervous system brain metastasis . Major surgical procedure , open biopsy , significant traumatic injury within 28 day prior Day 0 , anticipation need major surgical procedure course study . Minor surgical procedure fine needle aspiration core biopsy within 7 day prior Day 0 . Pregnant ( positive pregnancy test ) lactating . Urine calculate creatinine clearance le 45ml/minute urinary protein . Creatinine ratio 1 . History abdominal fistula , gastrointestinal perforation , intraabdominal abscess within 6 month prior Day 1 . Serious , nonhealing wound , ulcer , bone fracture . Inability comply study and/or followup procedure .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>